Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ranibizumab is a monoclonal antibody fragment obtained from the same parental murine antibody as bevacizumab. It is an anti-angiogenic drug that has been approved for the treatment of AMD patients.
This report presents a comprehensive overview, market shares and growth opportunities of Ranibizumab market by product type, application, key companies and key regions. Biomedicine has achieved rapid growth in the global pharmaceutical market due to its high pharmacological activity, strong specificity, and good therapeutic effect. In the biopharmaceutical market, the monoclonal antibody is the most subdivided category. With the development of biotechnology, the research on monoclonal antibodies will be further deepened, and the patients' demand for monoclonal antibodies will also be further increased. Ranibizumab is mainly used for the treatment of age-related macular degeneration (AMD), a retinal disease that increases the incidence with age and causes a significant decrease in vision. Diabetic retinopathy and diabetic macular edema can also be treated with ranibizumab. Therefore, the deepening of global aging and the increasing incidence of chronic diseases such as diabetes will promote the expansion of demand for ranibizumab.
Indian pharmaceutical company Intas Pharmaceuticals has launched RAZUMAB™, a biosimilar of Lucentis® (Ranibizumab). The product is entirely manufactured in India, and the price of RAZUMAB™ is much cheaper than Lucentis®, which will allow the drug to be used in a wider patient population.
The report details the trend, potential and market size of Ranibizumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Ranibizumabmarket, defines the market attractiveness level of Ranibizumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Ranibizumab industry, describes the types of Ranibizumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ranibizumab market and the development prospects and opportunities of Ranibizumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ranibizumab market in Chapter 13.
By Player:
Novartis
Genentech
By Type:
Single-use prefilled syringe
Single-use glass vial
By End-User:
AMD
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
mCNV
RVO
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Ranibizumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Ranibizumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Ranibizumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Ranibizumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Ranibizumab Market Analysis and Outlook to 2022
-
7.1 Global Ranibizumab Consumption (2017-2022)
-
7.2 United States Ranibizumab Consumption (2017-2022)
-
7.3 Europe Ranibizumab Consumption (2017-2022)
-
7.4 China Ranibizumab Consumption (2017-2022)
-
7.5 Japan Ranibizumab Consumption (2017-2022)
-
7.6 India Ranibizumab Consumption (2017-2022)
-
7.7 South Korea Ranibizumab Consumption (2017-2022)
8 Region and Country-wise Ranibizumab Market Analysis and Outlook to 2028
-
8.1 Global Ranibizumab Consumption Forecast (2022-2028)
-
8.2 United States Ranibizumab Consumption Forecast (2022-2028)
-
8.3 Europe Ranibizumab Consumption Forecast (2022-2028)
-
8.4 China Ranibizumab Consumption Forecast (2022-2028)
-
8.5 Japan Ranibizumab Consumption Forecast (2022-2028)
-
8.6 India Ranibizumab Consumption Forecast (2022-2028)
-
8.7 South Korea Ranibizumab Consumption Forecast (2022-2028)
9 Global Ranibizumab Market Outlook by Types and Applications to 2022
-
9.1 Global Ranibizumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Single-use prefilled syringe Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Single-use glass vial Consumption and Growth Rate (2017-2022)
-
9.2 Global Ranibizumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global AMD Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diabetic Retinopathy (DR) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diabetic Macular Edema (DME) Consumption and Growth Rate (2017-2022)
-
9.2.4 Global mCNV Consumption and Growth Rate (2017-2022)
-
9.2.5 Global RVO Consumption and Growth Rate (2017-2022)
10 Global Ranibizumab Market Outlook by Types and Applications to 2028
-
10.1 Global Ranibizumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Single-use prefilled syringe Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Single-use glass vial Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Ranibizumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global AMD Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diabetic Retinopathy (DR) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Diabetic Macular Edema (DME) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global mCNV Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global RVO Consumption Forecast and Growth Rate (2022-2028)
11 Global Ranibizumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Ranibizumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Ranibizumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Ranibizumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Ranibizumab Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Ranibizumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Ranibizumab Product and Service
-
14.2 Genentech
-
14.2.1 Genentech Company Details
-
14.2.2 Genentech Ranibizumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Genentech Ranibizumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Ranibizumab
-
Figure Ranibizumab Picture
-
Table Global Ranibizumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ranibizumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ranibizumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Ranibizumab Consumption by Country (2017-2022)
-
Figure United States Ranibizumab Consumption and Growth Rate (2017-2022)
-
Table Europe Ranibizumab Consumption and Growth Rate (2017-2022)
-
Figure China Ranibizumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Ranibizumab Consumption and Growth Rate (2017-2022)
-
Figure India Ranibizumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ranibizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Ranibizumab Consumption Forecast by Country (2022-2028)
-
Figure United States Ranibizumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ranibizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Ranibizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ranibizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ranibizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ranibizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Single-use prefilled syringe Consumption and Growth Rate (2017-2022)
-
Figure Global Single-use glass vial Consumption and Growth Rate (2017-2022)
-
Figure Global AMD Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetic Retinopathy (DR) Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetic Macular Edema (DME) Consumption and Growth Rate (2017-2022)
-
Figure Global mCNV Consumption and Growth Rate (2017-2022)
-
Figure Global RVO Consumption and Growth Rate (2017-2022)
-
Figure Global Single-use prefilled syringe Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Single-use glass vial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AMD Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetic Retinopathy (DR) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetic Macular Edema (DME) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global mCNV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RVO Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Ranibizumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Ranibizumab Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Ranibizumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Ranibizumab Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Ranibizumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Ranibizumab Product and Service
-
